Is hypothyroidism a risk factor for non-alcoholic steatohepatitis?

被引:141
|
作者
Liangpunsakul, S
Chalasani, N
机构
[1] Indiana Univ, Sch Med, Div Clin Pharmacol, Dept Med, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Div Gastroenterol Hepatol, Dept Med, Indianapolis, IN 46202 USA
关键词
hypothyroidism; non-alcoholic steatohepatitis; thyroid hormone replacement;
D O I
10.1097/00004836-200310000-00014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose: Thyroid hormones play an important role in the regulation of lipid and carbohydrate metabolism, both of which are affected in patients with non-alcoholic steatohepatitis (NASH). Anecdotally, we have observed that a number of patients with NASH carried a diagnosis of hypothyroidism. However, it is unknown if thyroid dysfunction plays any role in the pathogenesis of NASH. To further investigate this observation, we conducted a case-control study to determine the association between hypothyroidism and NASH. Subjects and Methods: Cases were defined as patients with well-documented NASH attending hepatology clinics at Indiana University Hospital from January 1, 1995 to December 31, 2000. Age, gender, race, and body-weight matched individuals seen during the same period in the general medical clinics served as controls. Patients with a previous diagnosis of hypothyroidism who are currently on synthetic T4 replacement were considered to be "hypothyroid". The strength of association was assessed by logistic regression analysis after controlling for the frequency of diabetes mellitus, hyperlipidemia, and hypertension. Results: One hundred and seventy-four patients with NASH (cases) and 442 controls were included. The mean age of cohort was 49 13 years, 59% were female, and 98% were white. The prevalence of hypothyroidism in patients with NASH was 15% and was significantly higher than in the controls (7.2%, P < 0.001). By multivariate analysis, the prevalence of hypothyroidism in the NASH group was significantly higher than in control group (OR: 2.3, 95% CI: 1.2-4.2, P = 0.008). Conclusion: These data suggest that hypothyroidism is associated with human NASH. Further research is needed to confirm this finding and to understand its implications.
引用
收藏
页码:340 / 343
页数:4
相关论文
共 50 条
  • [31] Selonsertib for non-alcoholic steatohepatitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (12): : 852 - 852
  • [32] Treatment of non-alcoholic steatohepatitis
    Angulo, P
    Lindor, KD
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2002, 16 (05) : 797 - 810
  • [33] Fructose and Non-Alcoholic Steatohepatitis
    Roeb, Elke
    Weiskirchen, Ralf
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [34] Metformin in non-alcoholic steatohepatitis
    Urso, R
    Visco-Comandini, U
    LANCET, 2002, 359 (9303): : 355 - 356
  • [35] Diagnosis of non-alcoholic steatohepatitis
    James, OFW
    STEATOHEPATITIS (NASH AND ASH), 2001, 121 : 34 - 39
  • [36] News on non-alcoholic steatohepatitis
    Roeb, E.
    Nitschmann, S.
    INTERNIST, 2022, 63 (02): : 238 - 242
  • [37] Non-alcoholic steatohepatitis (NASH)
    Michael F. Sorrell
    Sandeep Mukherjee
    Current Treatment Options in Gastroenterology, 1999, 2 (6) : 447 - 450
  • [38] Statins in Non-alcoholic Steatohepatitis
    Torres-Pena, Jose D.
    Martin-Piedra, Laura
    Fuentes-Jimenez, Francisco
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [39] Non-alcoholic Steatohepatitis: An Overview
    Shifflet, Allison
    Wu, George Y.
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2009, 108 (01) : 4 - 12
  • [40] Cannabis and non-alcoholic steatohepatitis
    Cohen, L. B.
    Neuman, M. G.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 51 - 51